Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong

BACKGROUND: Dabigatran is an oral direct thrombin inhibitor recently approved for stroke prevention in atrial fibrillation (AF) as an alternative to warfarin. The primary advantages of dabigatran are freedom from monitoring and less interaction with other drugs and food. It is ideal for patients who...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cardiol
Main Authors: Ho, Jason C. S., Chang, Andy M., Yan, Bryan P., Yu, Cheuk Man, Lam, Yat Yin, Lee, Vivian W. Y.
Format: Artigo
Language:Inglês
Published: Wiley Periodicals, Inc. 2012
Subjects:
Clinical Investigations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652425/
https://ncbi.nlm.nih.gov/pubmed/23108916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22069
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items